1 in 3 people over 40 has a fatty liver. Even TOFI (Thin Outside, Fat Inside) individuals may be affected.
76981
Covered by all major insurance providers. No prior authorization required.
FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management. PARIS and Waltham, MA – March 22, 2023 – The U.S. Food and Drug Administration (FDA) has cleared expanded Indications for Use for screening with FibroScan®, the non-invasive liver management
Fatigue, Headache, Dizziness, Exercise intolerance, Fainting, Tingling in the toes or fingers, Claudication, Painful muscle cramping in the hips, thighs, or calves when walking, climbing stairs, or exercising.
TM Flow focuses on early detection and follow-up of complications (autonomic nervous system & vascular system) of chronic metabolic diseases such as Diabetes. The TM Flow System includes the following tests to determine these clinical outcomes:
ANS 95921
SUDOMOTOR 95923
ABI 93922
All major insurance covered
With Prior Authorization
The American Diabetes Association recommends autonomic nervous system (ANS) testing as a standard of care for patients with Type 1 and Type 2 diabetes.
The American Heart Association Practice Guidelines for managing peripheral artery disease recommend measuring the ankle-brachial index (ABI) in adults over 50 with a history of smoking, diabetes, or circulation problems, as well as in all adults over 70.
Initial Consultation: 73564, 99204
First Injection: 73580, 27369, Q9967, J2920, 99123
Subsequent Injection: 77002, 20610, Q9967, J7320, 99212
DME: L1843, L2397
All major insurance covered
With Prior Authorization